Acute hepatitis B infection in England and Wales: 1985–96
Confirmed acute hepatitis B infections are reported to the Public Health Laboratory Service Communicable Disease Surveillance Centre by laboratories in England and Wales. These reports have been used to monitor trends in the incidence of hepatitis B virus (HBV) infection over time, and between expos...
Gespeichert in:
Veröffentlicht in: | Epidemiology and infection 1999-02, Vol.122 (1), p.125-131 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Confirmed acute hepatitis B infections are reported to the Public
Health Laboratory Service
Communicable Disease Surveillance Centre by laboratories in England and
Wales. These
reports have been used to monitor trends in the incidence of hepatitis
B virus (HBV) infection
over time, and between exposure categories and age groups. Between 1985
and 1996 a total of
9252 cases of acute HBV infection were reported; the number of reports
fell from 1761 in 1985
to 581 in 1996. Most infections were reported in adults aged 15–44
years [n=7365 (80%)],
and infections were more commonly reported in males [n=6490
(70%)] than females
[n=2658 (29%)]. The probable means of acquisiiton was
known for just over half of all adult
cases [4827/8956 (54%)]. Injecting drug use was the most
common exposure [n=1901 (21%)],
followed by sex between men and women [n=1140 (13%)]
and sex between men [n=1025
(11%)]. The number of infections in injecting drug users fell in the
late 1980s, but increased
again from 1991 onwards. In children aged under 15 years, infections acquired
by mother to
baby transmission accounted for 35/170 (21%) of the total. Surveillance
indicates that the
incidence of acute hepatitis B infection fell in the late 1980s, probably
reflecting changed
behaviour in injecting drug users. An increase in the number of infections
in injecting drug
users since 1993 may indicate ongoing transmission that has not been contained
by the
introduction of needle exchange schemes or by selective vaccination. |
---|---|
ISSN: | 0950-2688 1469-4409 |
DOI: | 10.1017/S0950268898001733 |